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ABBREVIATIONS 
 
CAD: coronary artery disease 
CKD: chronic kidney disease 
DM: diabetes mellitus 
ECG: electrocardiogram / electrocardiographic 
ESRD: end-stage renal disease 
HTN: hypertension 
LV: left ventricle 
LVEF: left ventricular ejection fraction 
RS: reversible score 
SD: standard deviation 
SPECT-MPI: single-photon emission computed tomography myocardial perfusion imaging 
SRS: summed rest score 
SSS: summed stress score 
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ABSTRACT 
Background: The patients with end stage renal disease (ESRD) represent a particularly 
challenging population as coronary artery disease (CAD) remains a leading cause of 
mortality, limiting the long term success of renal transplantation. Thus cardiovascular risk 
stratification is essential in the pre-transplant screening and may be performed non-invasively 
by modalities including single-photon emission computed tomography myocardial perfusion 
imaging (SPECT-MPI). The goal of this study was to evaluate the prevalence of changes in 
the SPECT-MPI and its relationship with cardiovascular risk factors, clinical manifestations 
of ischemia, electrocardiographic pattern and heart rate response to adenosine in patients with 
ESRD. 
Methods: We included 112 cases of consecutive patients with ESRD on dialysis, who were 
referred to our institution between October 2011 and April 2013, to perform SPECT-MPI for 
pre-operative risk stratification before renal transplant. Data was collected, including gender, 
age, the presence of risk factors for atherosclerosis (diabetes (DM), hypertension (HTN), 
dyslipidemia and smoking habits), rest heart rate, presence of previous angina and baseline 
ECG pattern. Gated SPECT-MPI was performed according to the protocol stress followed by 
rest images with Tc 99m-tetrafosmin. A 17 segment score system was used to semi-quantify 
the perfusion defects. A LVEF ≤ 45% was considered abnormal. Emory Toolbox Software 
was used for phase analysis and a standard deviation (SD) ≥ 43º was considered significant 
for mechanical dyssynchrony. 
Results: The mean age was 51.8  10.8 and the majority of patients were male. Myocardial 
perfusion abnormalities were presented in 22.3%. The QRS width (OR = 1.0, P value < 
0.005) and the rest heart rate (OR = 1.1, P value < 0.05) were independent predictors of an 
abnormal perfusion. An LVEF ≤ 45% was present in 13.4 % of the patients. The evidence of 
an ECG suggestive of myocardial hypertrophy (OR = 8.2, P value < 0.05), the baseline QRS 
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width (OR = 1.0, P value < 0.05) and the reference to previous angina (OR = 5.4, P value < 
0.05) were independent predictors of a LVEF ≤ 45%. Left ventricular dyssynchrony was 
observed in 16.1% of the studied population. The age (OR = 0.9, P value < 0.05) and the SRS 
(OR = 1.3, P value < 0.001) were independent predictors of mechanical dyssynchrony. 
Conclusions: An abnormal gated SPECT-MPI in this group of patients was not associated 
with the presence of cardiovascular risk factors. The changes on the ECG pattern were 
predictors of an abnormal perfusion and along with the electrocardiographical evidence of 
myocardial hypertrophy were also predictors of an impaired left ventricle function, with no 
relationship between them and the presence of mechanical dyssynchrony. The low frequency 
of perfusion abnormalities found in gated SPECT-MPI, which was also very heterogeneous in 
what concerns to age, justifies further studies to define the optimal population, protocol and 
image acquisition of gated SPECT-MPI when evaluating patients with ESRD. 
Key words: end stage renal disease • coronary artery disease • cardiovascular risk factors • 
myocardial perfusion imaging • ECG • left ventricular ejection fraction • ventricular 
dyssynchrony. 
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RESUMO 
Introdução: Os doentes com doença renal terminal (DRT) representam uma população 
particularmente desafiante dado que a doença arterial coronária (DAC) continua a ser uma das 
principais causas de morte nesta população, o que limita o sucesso a longo prazo do 
transplante renal. Deste modo, a estratificação do risco cardiovascular é fundamental na 
seleção de doentes para transplante e pode ser realizada de forma não invasiva pela CPM. O 
objetivo deste estudo foi avaliar a prevalência de alterações na cintigrafia de perfusão do 
miocárdio (CPM) e a sua relação com fatores de risco cardiovascular, manifestações clínicas 
de isquémia, padrão electrocardiográfico (ECG) e frequência cardíaca após a administração 
de adenosina em pacientes com DRT. 
Métodos: Foram incluídos 112 doentes consecutivos com DRT em diálise, que foram 
encaminhados para a nossa instituição entre Outubro de 2011 e Abril de 2013, para realizar 
CPM, de forma a estratificar o risco cardiovascular pré-operatório do transplante renal. Os 
dados colhidos incluíram o género, a idade, a presença de fatores de risco para aterosclerose 
(diabetes mellitus, hipertensão arterial, dislipidémia e tabagismo), a frequência cardíaca em 
repouso, a presença de angina prévia e o padrão eletrocardiográfico basal. A CPM foi 
realizada de acordo com o protocolo de esforço seguido pela obtenção de imagens em 
repouso, com o uso de Tc 99m-tetrafosmina. Um sistema de pontuação de 17 segmentos foi 
usado para semi-quantificar os defeitos de perfusão miocárdica. Uma FEVE ≤ 45% foi 
considerada anormal. O histograma de fase foi obtido pelo Emory Toolbox Software e um 
desvio padrão (SD) ≥ 43º foi considerado significativo para dessincronia mecânica. 
Resultados: A idade média foi de 51.8 ± 10.8 anos e a maioria dos pacientes eram do género 
masculino. Alterações da perfusão miocárdica estavam presentes em 22.3% dos pacientes. A 
duração do intervalo QRS (OR = 1.0, P < 0.005) e a frequência cardíaca em repouso (OR = 
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1.1, P < 0.05) foram preditores independentes de uma perfusão anormal. Uma FEVE ≤ 45 % 
estava presente em 13.4% dos doentes. A evidência de um ECG sugestivo de hipertrofia do 
miocárdio (OR = 8.2, P < 0.05), a duração do intervalo QRS (OR = 1.0, P < 0.05 ) e a 
referência a história prévia de angina (OR = 5.4, P < 0.05 ) foram preditores independentes de 
uma FEVE ≤ 45%. A dessincronia ventricular esquerda foi observada em 16.1% da população 
estudada. A idade (OR = 0.9, P < 0.05) e o SRS (OR = 1.3, P < 0.001) foram preditores 
independentes de dessincronia mecânica. 
Conclusões: As alterações da perfusão do miocárdio não tiveram qualquer relação com a 
presença de fatores de risco cardiovascular. As alterações no padrão de ECG foram preditoras 
de uma perfusão anormal e, juntamente com a evidência eletrocardiográfica de hipertrofia 
miocárdica, foram preditoras de uma função ventricular esquerda diminuída, sem relação com 
a presença de dessincronia mecânica. A baixa prevalência de defeitos de perfusão encontrada, 
que foi, de igual modo, muito heterogénea no que concerne a idade, justifica a necessidade 
premente de realizar mais estudos, de forma a definir o melhor protocolo e processo de 
aquisição de imagens mais adequado na CPM, bem como a população ideal a ser submetida a 
este exame, no que respeita à avaliação de pacientes com DRT em lista de espera para 
transplante renal. 
Palavras-chave: doença renal terminal • doença arterial coronária • fatores de risco 
cardiovascular • cintigrafia de perfusão do miocárdio • ECG • fração de ejeção do ventrículo 
esquerdo • dessincronia ventricular. 
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INTRODUCTION 
Cardiovascular disease is the leading cause of morbidity and mortality in patients with 
chronic kidney disease (CKD), particularly in those with end stage renal disease (ESRD) 
[1-6]
, 
where 45% of the overall mortality is attributed to cardiovascular causes 
[2, 7]
. In fact, the 
incremental risk of cardiovascular disease in those with CKD, compared to the age- and sex-
matched general population, ranges from 10- to 20-fold, depending on the stage, being CKD 
an independent risk factor for coronary artery disease (CAD) 
[1, 8-10]
. Therefore, the increased 
prevalence of vascular disease in CKD patients derives from both traditional and non-
traditional (CKD-related) risk factors. The first ones include hypertension (HTN), diabetes 
(DM) and dyslipidemia. The CKD-related risk factors include anemia, hyperphosphatemia, 
hyperparathyroidism and generalized inflammation 
[1, 3, 9, 11, 12]
. 
Patients with ESRD, with an indication for renal replacement therapy, represent a 
particularly challenging population as CAD remains a leading cause of mortality, limiting the 
long term success of renal transplantation. This procedure improves both survival and quality 
of life in this subgroup of patients. However, concerning the intense utilization of resources 
and the limited availability of donors, it is vital to offer this therapy to individuals most likely 
to achieve long-term benefit 
[1, 4]
. Thus, cardiovascular risk stratification is essential in the 
pre-transplant screening, helping to identify individuals that may require a more aggressive 
evaluation and treatment. Moreover, it helps to detect existing cardiac conditions amenable to 
risk modification, and to exclude individuals with such short life expectancy that 
transplantation would not yield acceptable benefit from the allograft 
[6, 8, 9, 11, 13-21]
. 
Among other techniques, testing for CAD may be performed non-invasively by 
modalities including single-photon emission computed tomography myocardial perfusion 
imaging (SPECT-MPI). It has been shown that these tests have prognostic value for mortality 
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but imperfect sensitivity and specificity for detecting angiographically-defined CAD in 
patients with renal failure 
[1, 4-6, 11, 13-15, 17, 21-24]
. However, encouraging results have been 
already reported 
[25-27]
, suggesting that this subject requires further evaluation. 
Nevertheless, SPECT-MPI is a powerful tool to diagnose CAD, identifying patients at 
high and low clinical risk, and aid in their treatment. It predicts adverse cardiovascular 
outcomes in CKD patients with known or suspected CAD, due to the provided data such as 
left ventricular (LV) function, myocardial perfusion defects and, likewise, the existence of 
ventricular dyssynchrony 
[7, 8, 16, 20, 22, 28-30]
.  
With this study, we intend to evaluate the prevalence of changes in the SPECT-MPI 
and its relationship with cardiovascular risk factors, clinical manifestations of ischemia, 
electrocardiographic pattern and heart rate response to adenosine in patients with ESRD. 
 
MATERIAL AND METHODS 
A. Patient population 
The study population was selected from a database of all patients with ESRD on 
dialysis, who were referred to our institution to perform SPECT-MPI for pre-operative risk 
stratification before renal transplant. From October, 1st of 2011, to April, 30th of 2013, 125 
SPECT-MPI were performed in these patients.  
In brief, demographic and clinical data was possible to collect from 112 cases, 
including gender, age, the presence of risk factors for atherosclerosis (diabetes (DM), 
hypertension (HTN), dyslipidemia and smoking habits), presence of previous angina and 
ischemic basal ECG as well as reference to an ECG suggestive of myocardial hypertrophy or 
bundle branch block, rest heart rate and baseline QRS width. Due to the presence of 
arrhythmia, gated SPECT was not possible to perform in 13 patients. 
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B. Protocol 
Gated SPECT-MPI was obtained at stress followed by rest with Tc-99m tetrafosmin. 
For stress images patients were injected with 370 to 555 MBq (10 to 15 mCi) of Tc-
99m tetrafosmin during adenosine protocol. Adenosine was infused at a dose of 140 
μg/Kg/min during 4 minutes and the tracer was injected at the end of the second minute. ST 
deviation during adenosine and heart rate after vasodilation were recorded for analysis.  
Rest images were acquired by injecting 740 to 1110 MBq (20 to 30 mCi) of the tracer, 
3 hours later if an abnormality (in perfusion and/or ventricular function) was noticed in stress 
images. The injected dose was calculated according to the weight of the patient. 
 Images were acquired 30 to 45 minutes after the injection of the tracer. They were 
performed by a hybrid system SPECT-CT, with a dual-head gama camera (BrightView XCT), 
using a stop and shoot acquisition, with 64 projections per study and a 180
o
 arc, from right 
anterior to left anterior oblique. A single low-dose CT (computed tomography) scan (helical, 
120 KeV, 1mA with 1.9 pitch) was acquired before stress and rest acquisitions for attenuation 
correction. 
C. Interpretation of images 
Images were visualized and classified as abnormal according to the presence of a 
perfusion defect (Figure 1). Concerning the current guidelines, a 17 segment score system was 
used to semi-quantify the perfusion defects, allowing to obtain a perfusion score (stress, rest 
and reversibility score). 
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The left ventricular ejection fraction 
(LVEF) was calculated automatically in patients 
with a regular cardiac rhythm. A LVEF equal or 
under to 45% was considered abnormal. Using 
Emory toolbox, left ventricular synchrony was 
also estimated through the values of the standard 
deviation (SD) on the phase histogram (Figure 2). 
According to the literature 
[30, 31]
, a phase SD 
equal or above 43
o
 is synonymous of significant 
ventricular dyssynchrony. 
D. Statiscal analysis 
 Continuous variables were presented as mean ± 1 standard deviation (M ± 1SD) and 
categorical variables were presented as their proportion in the total study population. 
A B 
Figure 1. A - Stress images presenting a perfusion defect in the inferior and lateral segments of the left ventricle 
without attenuation correction and an apical defect with attenuation correction. B - Rest images of the same 
patient presenting a perfusion defect in the inferior segment (smaller than in A) without attenuation correction 
and an almost normal exam with attenuation correction. 
Figure 2. Phase histogram of the patient in 
Figure 1 showing a SD < 43
o
. 
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Continuous variables were compared using the ANOVA and the nonparametric U-Mann-
Whitney test.  The Fisher´s exact test was used for categorical data. 
Considering the presence of an abnormal perfusion, a LVEF ≤ 45% and a SD ≥ 43º as 
the dependent variables, univariate logistic regression analysis was used to assess the 
predictors of perfusion defects (ischemia), impairment in LVEF (left ventricle dysfunction) 
and mechanical dyssynchrony. 
The level of statistical significance adopted was 0.05. All statistical analysis was 
performed using StatView 5.0.1, version for Macintosh and Windows, SAS Institute. 
 
RESULTS  
 The demographic, clinical and electrocardiographic data collected from the 112 
patients in this study are shown in Table 1. The mean age was 51.8  10.8 and the majority of 
patients were male. Over 60% of the patients had HTN and 25% were presented with an 
ischemic basal ECG. 
Table 1. Baseline characteristics 
Variables n = 112 (100%) 
Male gender 87 (77.7%) 
Age (years) 51.8  10.8 
Previous angina 12 (10.7%) 
DM 39 (34.8%) 
HTN 70 (62.5%) 
Dyslipidemia 28 (25%) 
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Smoking habits 10 (8.9%) 
ST segment /T wave changes 28 (25%) 
Baseline QRS width (ms) 107.8  23.6 
Bundle branch block 11 (9.8%) 
ECG suggestive of myocardial hypertrophy 7 (6.3%) 
Rest heart rate (beats/min) 70.3  10.9 
DM, Diabetes mellitus. HTN, Hypertension. ECG, Electrocardiogram. 
 
The adenosine stress test and imaging results collected from SPECT-MPI are 
presented in Table 2. Myocardial perfusion abnormalities, defined as a summed stress score 
(SSS) ≥ 1, were presented in 25 patients (22.3%). An LVEF equal or inferior to 45% was 
registered in 13.4% of the patients and about 16.1% had significant mechanical ventricular 
dyssynchrony (SD ≥ 43o). 
Table 2. SPECT-MPI results 
Variables n = 112 (100%) 
Adenosine heart rate (beats/min) 88.6  14.3 
ST depression during adenosine 3 (2.7%) 
Abnormal myocardial perfusion 25 (22.3%) 
SSS  2.6  5.8 
SRS 1.8  4.9 
RS  0.8  2.7 
LVEDV (mL) 110.2  57.4 
LVESV (mL) 52.9  38.1 
13 
LVEF (%) 61.3  13.6 
LVEF ≤  45% 15 (13.4%) 
SD  27.7  14.3 
SD ≥ 43º 18 (16.1%) 
SSS, Summed stress score. SRS, Summed rest score. RS, Reversibility score. LVEDV, Left ventricular end diastolic volume. 
LVESV, Left ventricular end systolic volume. LVEF, Left ventricular ejection fraction. SD, Standard deviation. 
 
In Table 3, clinical, electrocardiographic and adenosine stress test characteristics were 
compared in patients with and without myocardial perfusion defects. The major differences 
between patients with abnormal and normal myocardial perfusion were related with the rest 
QRS width (P < 0.005) and the presence of bundle branch block (P < 0.01). There were no 
significant differences between the incidence of the non-modifiable and modifiable risk 
factors for cardiovascular disease between both groups. 
Table 3. Myocardial perfusion defects 
 Abnormal perfusion 
 n = 25 (22.3%) 
Normal perfusion 
n = 87 (77.7%) 
P value 
Male gender 20 (80%) 67 (77%) ns 
Age (years) 52.1  11.8 51.7  10.6 ns 
DM 11 (44%) 28 (32.2%) ns 
Dyslipidemia 7 (28%) 21 (24.1%) ns 
HTN 17 (68%) 63 (72.4%) ns 
Smoking habits 2 (8%) 8 (9.2%) ns 
Rest heart rate (beats/min) 75.0  14.0 68.9  9.6 ns (0.06) 
ST segment/T wave changes 10 (40%) 18 (20.7%) ns (0.06) 
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DM, Diabetes mellitus. HTN, Hypertension. ECG, Electrocardiogram. 
 
Using logistic regression analysis, the univariate predictors of myocardial perfusion 
defects were, in this group, the baseline heart rate, the presence of ischemic changes in the 
baseline ECG, the baseline QRS width and, likewise, the evidence of bundle branch block 
(Table 4). 
A multivariate model was built with the variables found to be predictors of an 
abnormal perfusion in the univariate analysis (Table 5). This model has the QRS width in 
addition to the rest heart rate as independent predictors of an abnormal perfusion. It predicts 
correctly 83.6% of the cases, 97.7% of which were presented without any myocardial 
perfusion defects and 33.3% with an abnormal myocardial perfusion. 
Table 4. Univariate predictors of myocardial perfusion defects 
 Odds ratio 95% CI odds ratio P value 
Rest heart rate 1.0 0.9 - 1.0 < 0.05 
ST segment /T wave changes 2.6 1.0 - 6.6 < 0.05 
Bundle branch block 6 (24%) 5 (5.7%) < 0.01 
ECG suggestive of 
myocardial hypertrophy 
2 (8%) 5 (5.7%) ns 
Baseline QRS width 122.1  29.1 103.6  20.2 < 0.005  
Previous angina 3 (12%) 9 (10.3%) ns 
Adenosine heart rate 
(beats/min) 
92.2  15.9 87.6  13.8 ns 
ST depression during 
adenosine 
0 (0%) 3 (3.5%) ns 
15 
Bundle branch block 5.2 1.4 - 18.8 < 0.05 
Baseline QRS width 1.0 1.0 - 1.1 < 0.005 
 
Table 5. Multivariate model used to predict myocardial perfusion defects  
Likelihood test: 2 = 16.0; P value < 0.0001 
 Odds ratio 95% CI odds ratio P value 
Rest heart rate 1.1 1.0 - 1.1 < 0.05 
ST segment /T wave changes 3.0 1.0 - 9.0 ns 
Baseline QRS width 1.0 1.0 - 1.0 < 0.005 
 
 In Table 6, clinical, electrocardiographic and SPECT-MPI characteristics were 
compared in patients with LVEF ≤ 45% and LVEF > 45%. The major differences between 
these groups were related to the electrocardiographic changes (ischemic basal ECG, evidence 
of bundle branch block, ECG pattern of myocardial hypertrophy and the baseline QRS width) 
as well as to the SPECT-MPI results (abnormal myocardial perfusion, SSS and SRS). 
Table 6. Left ventricular ejection fraction 
 LVEF ≤ 45%  
n = 15 (13.4%) 
LVEF > 45%  
n = 97 (86.7%) 
P value 
Male gender 11 (73.3%) 76 (78.4%) ns 
Age (years) 51.1  11.3 51.8  10.8 ns 
DM 5 (33.3%) 34 (35.1%) ns 
Dyslipidemia 5 (33.3%) 23 (23.7%) ns 
HTN 9 (60%) 61 (62.9%) ns 
Smoking habits 2 (13.3%) 8 (8.2%) ns 
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DM, Diabetes mellitus. HTN, Hypertension. ECG, Electrocardiogram. SSS, Summed stress score. SRS, Summed rest score. 
RS, Reversibility score. 
 
Using logistic regression analysis, the univariate predictors of LVEF ≤ 45% were, in 
this group, the electrocardiographic changes, the reference to previous angina and the SRS 
(Table 7). 
The multivariate model (Table 8) showed that the evidence of an ECG suggestive of 
myocardial hypertrophy, the baseline QRS width and the reference to previous angina were 
independent predictors of a LVEF ≤ 45%. This model, predicted appropriately 91.7% of the 
cases: 100% of which were presented with a LVEF > 45% and 40% with a LVEF ≤ 45%. 
Rest heart rate (beats/min) 76.3  15.2 69.3  9.8 ns 
ST segment/T wave 
changes 
7 (46.7%) 21 (21.6%) < 0.05 
Bundle branch block 5 (33.3%) 6 (6.2%) < 0.01 
ECG suggestive of 
myocardial hypertrophy 
3 (20%) 4 (4.1%) < 0.05 
Baseline QRS width (ms) 123.1  31.8 105.4  21.3 < 0.05 
Previous angina 4 (26.7%) 8 (8.2%) ns (0.06) 
Adenosine heart rate 
(beats/min) 
91.5  16.4 81.1  14 ns 
ST depression during 
adenosine 
0 (0%) 3 (3.2%) ns 
SSS 5.5  7.5 2.2  5.4 < 0.05 
SRS 4.7  7.6 1.4  4.2 < 0.05 
RS 0.8  1.7  0.8  2.8 ns 
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Table 7. Univariate predictors of LVEF ≤ 45% 
 Odds ratio 95% CI odds ratio P value 
ST segment /T wave 
changes 
3.2 1.0 - 9.7 < 0.05 
Bundle branch block 7.6 2.0 - 29.4 < 0.005 
ECG suggestive of 
myocardial hypertrophy 
5.8 1.2 - 29.2 < 0.05 
Baseline QRS width 1.0 1.0 - 1.1 < 0.05 
Previous angina 4.0 1.0 - 15.7 < 0.05 
SSS 1.1 1.0 - 1.2 ns (0.06) 
SRS 1.1 1.0 - 1.2 < 0.05 
ECG, Electrocardiogram. SSS, Summed stress score. SRS, Summed rest score. 
 
Table 8. Multivariate predictors of LVEF ≤ 45%  
Likelihood test: 2 = 15.8; P value < 0.0001 
 Odds ratio 95% CI odds ratio P value 
ST segment/T wave 
changes 
3.3 0.9 - 12.3 ns 
ECG suggestive of 
myocardial hypertrophy 
8.2 1,4 - 50.8 < 0.05 
Baseline QRS width 1.0 1.0 - 1.0 < 0.05 
Previous angina 5.4 1.1 - 26.5 < 0.05 
SRS 1.1 0.9 - 1.2 ns 
ECG - Electrocardiogram; SRS - Summed rest score. 
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In Table 9, we compared clinical, electrocardiographic and SPECT-MPI 
characteristics in patients with a SD ≥ 43o and SD < 43º, defining left ventricle mechanical 
dyssynchrony. The major differences between both groups were related to the age and the 
scores obtained with SPECT-MPI (SSS and SRS) as well as a LVEF ≤ 45%. 
Table 9. Left ventricle mechanical dyssynchrony 
 SD ≥ 43º 
n = 18 (16.07%) 
SD < 43º  
n = 94 (83.9%) 
P value 
Male gender 15 (83.3%) 72 (76.6%) ns 
Age (years) 47.1  9.3 52.6  10.9 < 0.05 
DM 8 (44.4%) 31 (33.0%) ns 
Dyslipidemia 7 (38.9%) 21 (22.3%) ns 
HTN 9 (50%) 61 (64.9%) ns 
Smoking habits 3 (16.7%) 7 (7.4%) ns 
Rest heart rate (beats/min) 72.2  13.2 69.9  10.5 ns 
ST segment/T wave changes 7 (38.9%) 21 (22.3%) ns 
Bundle branch block 2 (11.1%) 9 (9.6%) ns 
ECG suggestive of 
myocardial hypertrophy 
2 (11.1%) 5 (5.3%) ns 
Baseline QRS width (ms) 112.6  24.3 106.8  23.5 ns 
Previous angina 3 (16.7%) 9 (9.6%) ns 
Adenosine heart rate 
(beats/min) 
87.3  15.0 88.8  14.3 ns 
ST depression during 
adenosine 
0 (0%) 3 (3.2%) ns 
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DM - Diabetes mellitus; HTN - Hypertension; ECG, Electrocardiogram. SSS, Summed stress score. SRS, Summed rest score. 
RS, Reversibility score. 
 
With the logistic regression analysis, we found that the age, a LVEF ≤ 45% and the 
scores obtained with SPECT-MPI, mainly SSS and SRS, were the univariate predictors of 
mechanical dyssynchrony (Table 10). 
Table 11 shows the multivariate model for this group, which had the age, a LVEF ≤ 
45% and the SRS as independent variables, being the first one a protective factor of 
mechanical dyssynchrony (Odds ratio = 0.9, P < 0.05). It predicts correctly 89.0% of the 
cases, 97.8% of which were presented with a SD ≥ 43o and 44.4 % with a SD < 43o. 
Table 10. Univariate predictors of left ventricle mechanical dyssynchrony 
 Odds ratio 95% CI odds ratio P value 
Age 0.9 0.9 - 1.0 < 0.05 
LVEF ≤ 45% 0.9 0.9 - 1.0 < 0.0001 
SSS 1.2 1.1 - 1.3 < 0.0005 
SRS 1.2 1.1 - 1.4 < 0.001 
LVEF, left ventricular ejection fraction. SSS, Summed stress score. SRS, Summed rest score.  
 
LVEF ≤ 45% 47.6  12.4 64.0  12.2 < 0.0001 
SSS 8,6  10.1 1.5  3.6 < 0.005 
SRS 6.9  9.6 0.8  2.3 < 0.01 
RS 1.7  4.5 0.6  1.8 ns 
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Table 11. Multivariate predictors of left ventricle mechanical dyssynchrony  
Likelihood test: 2 = 35.3; P value < 0.0001. 
 Odds ratio 95% CI odds ratio P value 
Age 0.9 0.9 - 1.0 < 0.05 
LVEF ≤ 45% 0.9 0.9 - 1.3 < 0.005 
SRS 1.2 1.0 - 1.4 < 0.05 
LVEF, left ventricular ejection fraction. SSS, Summed stress score. SRS, Summed rest score. 
 
DISCUSSION 
 This is a study that involves a group of consecutive patients with ESRD on dialysis 
referred to gated SPECT-MPI for risk stratification before renal transplantation. Our aim was 
to find a relationship between the prevalence of changes in the SPECT-MPI and 
cardiovascular risk factors, clinical manifestations of ischemia, electrocardiographic pattern, 
as well as heart rate response to adenosine in this group of patients. 
 The mean age of this group was 51.8 years, approximately 78% were male and 62.5% 
of the patients had HTN, being the prevalence of DM also considerable among them (34.8%). 
In summary, the present study relies on a heterogeneous population in what concerns to age, 
with the majority of patients under 60 years old (a minimum of 27 and a maximum of 76 
years), already with a high prevalence of traditional cardiovascular risk factors, namely HTN, 
which can be explained as a cause or, more consistently, as a consequence of the severe renal 
dysfunction 
[32]
. 
 In previous studies, there is reference to variable and more often reduced sensitivities 
(37-90%) and specificities (40-90%) of SPECT-MPI in patients with ESRD 
[4]
. There is no 
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definitive explanation to this fact, but it has been speculated that it could be related to the 
increased circulating levels of adenosine in some patients with CKD, a reduced coronary flow 
reserve or even the presence of left ventricular hypertrophy 
[16]
. Moreover, we could not 
discard the possibility that diverse values are obtained with different protocols in the 
acquisition of the images with the gated SPECT-MPI. Attenuation correction seems to 
improve the specificity of the test according to Mathur et al. 
[33]
. In this study, a low 
prevalence of perfusion abnormalities had been found (n = 25, 22.3%), which could always 
raise the question of sensitivity and the doubt related with a negative test 
[1, 4]
. 
 Univariate and multivariate logistic regression analysis were performed and we found 
that in these patients the independent predictors of myocardial perfusion defects were the 
QRS width (OR = 1.0, P value < 0.005) and the rest heart rate (OR = 1.1, P value < 0.05). 
Regarding the cardiovascular risk factors analyzed, although the sample of patients with an 
abnormal perfusion is reduced, the presence of DM is higher in this group (n = 11, 44%) 
comparatively to the patients with a normal perfusion (n = 28, 32.2%), even though it was not 
statistically significant. HTN appears with an identical prevalence in both groups with an 
abnormal and normal perfusion, consistent with the high prevalence in the overall population, 
being this factor, as mentioned, a possible cause or effect of the CKD 
[32]
. An increased 
baseline heart rate is a well known marker of disease, particularly in situations of metabolic or 
hemodynamic stress 
[34, 35]
. Therefore, it was expected to be more elevated in the patients with 
perfusion defects, with an almost significant statistical difference (P value < 0.06). Similar 
results were found comparing the presence of an ischemic ECG in these groups, being more 
prevalent in the group with an abnormal perfusion (P value < 0.06). The presence of 
variations in the baseline QRS width, mainly the presence of bundle branch block, was the 
characteristic that showed a more significant statistical difference between the groups with an 
abnormal and normal perfusion. In fact, perfusion defects are known to be a common cause of 
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changes in the cardiac electrical conduction. Nonetheless, the bundle branch block, namely 
the left bundle branch block, is frequently associated with anteroseptal perfusion defects that 
are not always an expression of CAD but have a definite prognostic value 
[36-38]
. 
 Concerning the LVEF, only 15 patients showed a LVEF ≤ 45% (13.4%). However, in 
spite of the small sample, it was evident the higher prevalence of ECG changes in this group: 
ischemic pattern (P value < 0.05), variations in baseline QRS width and bundle branch block 
(P value < 0.05 and < 0.01, respectively) as well as evidence of myocardial hypertrophy (P 
value < 0.05). Univariate and multivariate logistic regression analysis were performed and it 
was found that regarding these variables the independent predictors of a LVEF ≤ 45% were 
the QRS width (OR = 1.0, P value < 0.05) and an ECG suggestive of myocardial hypertrophy 
(OR = 8.2, P value < 0.05). The ECG alterations, particularly the increased duration of the 
QRS interval and the presence of a bundle branch block pattern, could lead to changes in the 
ventricular synchrony, causing a diminished LVEF 
[39]
. On the other hand, an ischemic ECG 
could be associated to the presence of established ischemia, which is likewise a cause of 
contractility changes and reduced LVEF. The evidence of left ventricular hypertrophy, most 
likely related to volume overload in patients with advanced CKD, with an undoubtable 
relationship with HTN, could thus be a consequence of the disease or a preexisting condition 
[40, 41]
, and lead to ventricular dyssynchrony. A clinical history of previous angina was more 
prevalent in the patients with a LVEF ≤ 45% and was an independent predictor of this feature 
(OR = 5.4, P value < 0.05) as a clinical manifestation of ischemia that could lead to an 
impaired left ventricle function. Its influence in ventricular function and not in perfusion 
abnormalities could make us suspect of false negative results of perfusion or even small 
vessels disease. As we expected, this group of patients revealed increased values on the 
SPECT-MPI scores (SSS and SRS) with a significant statistical difference in comparison to 
those with a normal left ventricle function. 
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 The presence of mechanical ventricular dyssynchrony, defined as a SD ≥ 43o, seemed 
to be influenced by an abnormal perfusion, with the SPECT-MPI scores increased in this 
group of individuals, with a significant statistical difference. This was also observed in several 
other studies 
[7, 30, 42-45]
. The age was also an independent predictor of mechanical 
dyssynchrony (OR = 0.9, P value < 0.05). Surprisingly, it was more prevalent at a younger 
age. As expected, there was a clear relationship between mechanical dyssynchrony and a 
LVEF ≤ 45% (OR = 0.9; P value < 0.0001). Furthermore, it is important to note that in this 
group of patients the presence of a mechanical ventricular dyssynchrony had no significant 
relationship with the baseline QRS width, although a wider QRS is seen in these individuals. 
As stated by previous studies, mechanical dyssynchrony could be identified in patients with a 
normal QRS width 
[43]
 and it is more prevalent in the presence of ESRD, even in the absence 
of electrical dyssynchrony and abnormal LV perfusion 
[42]
. This higher prevalence happens in 
CKD patients already prior to dialysis treatment and is associated with left ventricle 
hypertrophy, left ventricular dysfunction and load conditions, which underlines the relevance 
of volume status for mechanical dyssynchrony in this group of patients 
[46-48]
. 
 This investigation was a single-center retrospective study that included only patients 
on the waiting list for kidney transplantation, with no reference to the time interval between 
the beginning of the CKD or the occurrence of the last session of hemodialysis and the 
performance of the exam. In addition, gated SPECT-MPI was not repeated unless clinically 
warranted, limiting our ability to follow the progression of the disease. Likewise, it was not 
possible to have access to the coronary angiography performed in the patients with positive 
results on the SPECT-MPI until the end of this study. Moreover, the observations could not 
be extended to the post-transplant period, since most of these patients are still waiting for 
surgery. 
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CONCLUSIONS  
In this study it was found that an abnormal gated SPECT-MPI in ESRD patients, with 
perfusion defects, impaired LVEF and/or evidence of mechanical dyssynchrony were not 
associated with the presence of the most common risk factors for atherosclerotic disease 
(gender, age, DM, dyslipidemia, HTN and smoking habits).  
A history of angina and an increased rest heart rate were higher in patients with 
perfusion defects, lower EF and mechanical dyssynchrony, although the rest heart rate was the 
only predictor of perfusion abnormalities and the history of angina predictor of a LVEF ≤ 
45%. The changes on the ECG pattern, namely the presence of variations in the baseline QRS 
width, including the bundle branch block, were associated with an abnormal perfusion. These 
variations along with the electrocardiographical evidence of myocardial hypertrophy were 
also predictors of an impaired left ventricle function. Mechanical dyssynchrony was 
associated to younger patients with a lower LVEF and higher perfusion scores. 
To clarify the low prevalence of perfusion abnormalities and also some surprising 
findings, such as the influence of angina in ventricular function and not in perfusion 
abnormalities, further studies are necessary. In our point of view, it is essential to define a 
homogeneous protocol when evaluating patients with ESRD on the waiting list for 
transplantation.  
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